INDP — Indaptus Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $18.19m
- $8.45m
- 10
- 17
- 69
- 23
Annual cashflow statement for Indaptus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -47.6 | -14.1 | -7.71 | -14.3 | -15.4 |
| Depreciation | |||||
| Non-Cash Items | 17.2 | 1 | 1.49 | 2.82 | 2.53 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.508 | 0.413 | -5.07 | -1.58 | -0.518 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -29 | -11.5 | -11.3 | -13.1 | -13.4 |
| Capital Expenditures | -0.921 | -0.022 | -0.004 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.29 | 0.772 | 0.452 | -16.4 | 17.1 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -3.21 | 0.75 | 0.448 | -16.4 | 17.1 |
| Financing Cash Flow Items | — | 0.071 | 20.7 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 2.37 | 16 | 48.3 | 0 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -30 | 5.38 | 37.5 | -29.5 | 3.74 |